Pedro C.
- Country
- Portugal
- Department
- Serviço de Nefrologia
Research Overview
- Efficacy and Safety of Oral BI 764198 in Adults and Adolescents with Primary or TRPC6-Variant Genetic Focal Segmental Glomerulosclerosis: A Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
Data & Insights
Has run more than one trial at 26 of 303 partner sites.
Specializations
Stroke Prevention Research
The investigator specializes in the prevention and treatment of ischemic stroke and related cerebrovascular conditions. Their research focuses on innovative therapeutic approaches for patients who have experienced acute non-cardioembolic stroke events.
- Post-stroke Prevention
- Cerebrovascular Disease Management
- Transient Ischemic Attack Treatment
A particular area of interest includes preventive therapies for patients following high-risk transient ischemic attacks.
Antithrombotic Medicine
The investigator's work encompasses advanced antithrombotic therapy approaches, with specific attention to novel oral anticoagulants and their role in stroke prevention.
- Blood Clot Prevention
- Antiplatelet Therapy
- Factor XI Inhibition
Their research includes evaluation of combination therapeutic strategies involving background antiplatelet therapy.
Clinical Safety Assessment
The investigator conducts comprehensive evaluations of bleeding risk in antithrombotic treatments, utilizing International Society on Thrombosis and Hemostasis criteria.
- Bleeding Risk Assessment
- Safety Monitoring
- Risk-Benefit Analysis
Their work involves careful assessment of therapeutic safety in cerebrovascular disease treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.